Key points are not available for this paper at this time.
Endothelial Cav-1 may modulate post-stroke thrombo-inflammation; leaves open whether Cav-1/RXR-γ targeting alters clinical outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ayman ElAli (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: